Pakistan on Monday signed an agreement with Pfizer Pakistan under which it would receive 13 million doses of the American vaccine.
On the other hand, over 600 diplomats from 57 countries have been vaccinated at the National Institute of Health (NIH).
According to a statement issued by a publicity firm, the agreement was signed by Pfizer Pakistan and the National Disaster Management Authority (NDMA) to supply 13 million doses of the Pfizer-BioNTech vaccine (BNT162b2). Deliveries are planned during the course of 2021.
“We are deeply honoured to work with the Pakistani government and to marshal our scientific and manufacturing resources toward our shared goal of bringing a Covid-19 vaccine to the people of Pakistan as quickly as possible,” said Pfizer Pakistan Country Manager Syed Mohammad Wajeehuddin in a statement.
“In the face of this global health crisis, Pfizer’s purpose — breakthroughs that change patients’ lives — has taken on an even greater urgency. Our hope is that our vaccine will help make this happen,” he said.
Chief Business and Chief Commercial Officer at BioNTech Sean Marett also thanked the Pakistani government for its support and putting trust in their ability to develop a vaccine that, they believed, had the potential to help address this global pandemic threat.
“Our goal remains to deliver a global supply of a well-tolerated and effective Covid-19 vaccine for many people around the world, as quickly as we can,” Mr. Marett said.
Pfizer and BioNTech aim to manufacture more than three billion doses of the vaccine globally by the end of this year.
Meanwhile, The National Command and Operation Centre (NCOC) reported 27 deaths and 663 new cases in the last 24 hours, with the number of active cases recorded at 39,017.
As many as 2,497 patients were under treatment in hospitals across the country and 283 on ventilators.
